Literature DB >> 12114653

Hormonally Functional Ovarian Neoplasms.

Lawrence M. Roth, Steven D. Billings.   

Abstract

Hormonally functional ovarian neoplasms are those tumors that secrete one or more hormones that are clinically manifested in the patient. The hormone production may have implications for the diagnosis, management or treatment of the patient. Hormonally functional ovarian neoplasms include tumors that belong to various histologic categories and produce a variety of hormonal effects. Functional ovarian tumors most commonly produce steroid hormones, and such tumors frequently belong in the sex cord-stromal and steroid cell categories. In addition, a wide variety of peptide hormones may be produced by ovarian tumors. Although in most instances the neoplastic cells themselves produce the hormones, a wide variety of tumors may induce their stroma to produce steroid hormones. The stroma of ovarian tumors is derived from the ovarian stroma and may, on occasion, resemble specialized ovarian stroma and its derivatives. Cells resembling luteinized stromal cells or luteinized theca cells may be present and appear to be responsible for the resultant hormone secretion.

Entities:  

Year:  2000        PMID: 12114653     DOI: 10.1385/ep:11:1:1

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  81 in total

1.  Struma ovarii. A report of 7 cases and a review of the subject.

Authors:  C C MARCUS; S L MARCUS
Journal:  Am J Obstet Gynecol       Date:  1961-04       Impact factor: 8.661

2.  Ovarian dysgerminoma: immunocytochemical localization of human chorionic gonadotropin in the germinoma cell cytoplasm.

Authors:  T J Mullin; M R Lankerani
Journal:  Obstet Gynecol       Date:  1986-09       Impact factor: 7.661

3.  Ectopic prolactin secretion from a gonadoblastoma.

Authors:  W H Hoffman; R R Gala; K Kovacs; M G Subramanian
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

4.  Ovarian stromal tumors containing Leydig cells. II. Pure Leydig cell tumor, non-hilar type.

Authors:  L M Roth; W H Sternberg
Journal:  Cancer       Date:  1973-10       Impact factor: 6.860

5.  Ultrastructural analysis of small cell carcinomas of the ovary.

Authors:  J T McMahon; W R Hart
Journal:  Am J Clin Pathol       Date:  1988-11       Impact factor: 2.493

6.  Alpha and beta subunits of inhibin/activin as sex cord-stromal differentiation markers.

Authors:  W Zheng; C J Sung; I Hanna; G DePetris; G Lambert-Messerlian; M Steinhoff; S C Lauchlan
Journal:  Int J Gynecol Pathol       Date:  1997-07       Impact factor: 2.762

Review 7.  Dysgerminoma of the ovary with hypercalcemia associated with elevated parathyroid hormone-related protein.

Authors:  H Inoue; Y Kikuchi; J Hirata; S Wada; K Seki; I Nagata
Journal:  Jpn J Clin Oncol       Date:  1995-06       Impact factor: 3.019

8.  Functioning ovarian tumors in postmenopausal women.

Authors:  R M Rome; D W Fortune; M A Quinn; J B Brown
Journal:  Obstet Gynecol       Date:  1981-06       Impact factor: 7.661

Review 9.  Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases.

Authors:  R H Young; R E Scully
Journal:  Am J Surg Pathol       Date:  1985-08       Impact factor: 6.394

10.  Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein.

Authors:  R H Young; A R Perez-Atayde; R E Scully
Journal:  Am J Surg Pathol       Date:  1984-09       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.